Back to search results
NCT06133439

Rural Indiana Screening for Colorectal Cancer

Enrolling by Invitation
NAAges 45–75InterventionalScreening
Indiana University
~11 participants
Updated 2026-04-14 on ClinicalTrials.gov
What's tested:Colorectal Screen rates with implementation of evidence-based intervention

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Effectiveness and Maintenance
Measured over Up to 12 months
+2 more outcomes measured

Conditions

Colorectal Cancer

Explore related trials

Colorectal Carcinoma

Where it's being run

1 sites across 1 states
Indiana1

Study leadership

  • Victoria Champion, PhD · PRINCIPAL_INVESTIGATOR · Indiana University

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

All participants will be staff employed at the respective clinics. Patients will be age 45 to 75 and either male or female. Age limitations are necessary because colorectal cancer screening doesn't start until 45 and ends at 75.

Exclusion

Under surveillance (inherited familial syndromes),history of inflammatory bowel disease, and a previous adenomatous polyp, or previous colorectal cancer.

What this trial measures

  • Effectiveness and MaintenanceUp to 12 months

    The primary effectiveness measure will be the rate of uptake of a complete episode CRC screening, a rate that includes resolution of a positive FIT test with diagnostic colonoscopy.

  • Contextual factorsUp to 12 months

    Contextual factors will be measured at the beginning of Phase 2 and during the midpoint and end of Phase 3. Semi structured items are used for contextual factors and are guided by the iPARIHS framework. The final contextual factor construct assessed during the interview will be readiness to engage in implementation of the EBI, measured by the Organizational Readiness to Change Assessment (ORCA).

  • Implementation outcomesUp to 36 months

    Measured by CC tracking forms, clinic logs that record all PN calls, adaptations to the implementation plan, fidelity measures and costs. The Clinic Implementation Tracking Form contains all essential tasks in the implementation plan including the dose and quality of intervention delivery. Overall quality of implementation and responsiveness to facilitation will be rated on a scale of 1 to 3. At the end of Phase 3, the investigators will interview two staff/clinic about their perceptions of the implementation. The investigators will also measure responses to a validated Acceptability scale using two staff/clinic at each clinic. All adaptations to the implementation plan will be recorded including rationale for change. Cost-data will be collected in phase 1 for usual care CRC screening promotion/education activities and throughout Phase 2 and 3 of implementation.